In the media – Autolomous to Expedite Digitization of Batch Verification.

Our announcement has been picked up by Contract Pharma:

“Autolomous LTD, a developer of critical manufacturing management systems for cell and gene therapies, received a loan from UK Research and Innovation (UKRI), the public innovation agency, to help address manufacturing challenges.

Autolomous will work to expedite development of AutoloMATE-Assist, its digital batch verification technology for cell and gene therapies (CGT). The project began in April 2021 and is expected to last 24 months.

AutoloMATE-Assist is the third module from Autolomous’ digital platform AutoloMATE. This digital platform aims to address efficiency, scalability and process streamlining of the GMP manufacturing and batch verification of cell & gene therapies. The other AutoloMATE modules are AutoloMATE-eBMR, which digitizes batch manufacturing records, and AutoloMATE-CLOCK that provides scheduling of all critical manufacturing variables.”